The Clorox Company
CLX
$89.11
$0.210.24%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.67B | 1.67B | 1.43B | 1.99B | 1.67B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.67B | 1.67B | 1.43B | 1.99B | 1.67B |
| Cost of Revenue | 948.00M | 951.00M | 833.00M | 1.06B | 926.00M |
| Gross Profit | 722.00M | 722.00M | 596.00M | 924.00M | 742.00M |
| SG&A Expenses | 407.00M | 452.00M | 444.00M | 469.00M | 477.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.00M | 6.00M | 5.00M | 6.00M | -3.00M |
| Total Operating Expenses | 1.39B | 1.44B | 1.31B | 1.57B | 1.43B |
| Operating Income | 284.00M | 235.00M | 119.00M | 417.00M | 241.00M |
| Income Before Tax | 256.00M | 215.00M | 107.00M | 410.00M | 254.00M |
| Income Tax Expenses | 65.00M | 54.00M | 25.00M | 74.00M | 63.00M |
| Earnings from Continuing Operations | 191.00M | 161.00M | 82.00M | 336.00M | 191.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.00M | -4.00M | -2.00M | -4.00M | -5.00M |
| Net Income | 187.00M | 157.00M | 80.00M | 332.00M | 186.00M |
| EBIT | 284.00M | 235.00M | 119.00M | 417.00M | 241.00M |
| EBITDA | 342.00M | 290.00M | 175.00M | 467.00M | 296.00M |
| EPS Basic | 1.54 | 1.29 | 0.65 | 2.70 | 1.51 |
| Normalized Basic EPS | 1.30 | 1.06 | 0.48 | 1.99 | 1.08 |
| EPS Diluted | 1.54 | 1.29 | 0.65 | 2.69 | 1.50 |
| Normalized Diluted EPS | 1.30 | 1.05 | 0.48 | 1.98 | 1.07 |
| Average Basic Shares Outstanding | 121.36M | 121.60M | 122.63M | 123.17M | 123.37M |
| Average Diluted Shares Outstanding | 121.79M | 121.92M | 123.02M | 123.74M | 124.07M |
| Dividend Per Share | 1.24 | 1.24 | 1.24 | 1.24 | 1.24 |
| Payout Ratio | 80.21% | 96.18% | 188.75% | 45.18% | 80.65% |